We imagine a world where new medicines reach patients in months, not years, and where scientific breakthroughs happen at the speed of thought.
Mithrl is building the world’s first commercially available AI Co-Scientist for drug discovery. Our platform transforms messy biological data into insights in minutes. Scientists ask questions in natural language, and Mithrl responds with real analysis, novel targets, hypotheses, and patent-ready reports.
Our knowledge graph platform sits at the intersection of ontology, machine learning, and scientific reasoning. It ingests unstructured literature, clinical trial data, and proprietary datasets, mapping them onto a structured biological knowledge layer that our R&D Decision Engine queries in real time.
Design is not an afterthought at Mithrl. Our first hire was a designer. We are a design-first company building at the frontier of applied AI, and we treat the interface between scientists and data as one of the hardest and most important problems we have.
Our customers are building some of the most important drugs in the world:
•
12X year-over-year revenue growth
•
Driving real breakthroughs from target discovery to patient outcomes
•
Enterprise Success: We currently serve 8 of the top 20 global research giants, counting industry leaders like J&J and Roche as part of our early Enterprise customers (historically unprecedented for any startup)